Interaction of heparins with fibroblast growth factors: conformational aspects.
Heparin and heparin-like oligo- and polysaccharides bind to fibroblast growth factors (FGFs) and modulate their ability to form active ternary complexes with FGF receptors (FGFRs). Considerable efforts have been made in recent years to identify the minimal heparin and heparan sulfate (HS) sequences that bind and activate individual FGFs. Heparin sequences involved in interaction with FGFs invariably contain at least one residue of 2-O-sulfated iduronic acid (IdoA2S), which adopts either the (1)(4) chair conformation or the equi-energetic skew-boat (2)S(0). In solution and in the absence of a binding protein, both these conformations are present in a dynamic equilibrium. In oligosaccharide-protein co-crystals, the protein selects those conformers that provide optimal contacts. The crystalline structure of a heparin hexasaccharide/FGF complex exhibits one of the two IdoA2S residues in the active site of the growth factor in (1)C(4) conformation and the other (outside the active site) in (2)S(0) conformation. NMR studies suggest that active conformations of heparin/HS oligosaccharides in solution could be distinct from those adopted in crystals. Heparin tetrasaccharides in the presence of FGF1 and FGF2 have both their IdoA2S residues prevalently in the (1)C(4) form. Current NMR and molecular modelling studies are being extended to longer heparin oligosaccharides as well as to heparins with "glycol-split" residues along their chains.
Guerrini
Marco
M
G. Ronzoni, Institute for Chemical and Biochemical Research, Milan, Italy. guerrini@ronzoni.it
Hricovíni
Milos
M
Torri
Giangiacomo
G
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D002236:Carbohydrate Conformation; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006493:Heparin / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D006497:Heparan Sulfate / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D009682:Magnetic Resonance Spectroscopy
D020533:Angiogenesis Inhibitors; D005346:Fibroblast Growth Factors; D006493:Heparin; D006497:Heparan Sulfate